Failure to Provide and Follow Ordered Pressure Ulcer Treatments
Summary
The deficiency involves the facility’s failure to provide pressure ulcer care consistent with professional standards for one resident with multiple pressure injuries. The resident was admitted with diagnoses including osteomyelitis, generalized muscle weakness, and hypertension, and had intact cognitive skills and capacity to make decisions per the H&P and MDS. A physician order dated 2/6/2026 directed daily treatment to a stage 4 sacrococcyx pressure ulcer extending to the bilateral buttocks, with a plan to reevaluate on 3/9/2026. A wound assessment on 3/4/2026 documented the stage 4 ulcer with specific measurements and noted that the wound provider performed debridement and ordered Santyl with calcium alginate daily and as needed. However, review of the Treatment Administration Record for March showed no documented wound treatment to the sacrococcyx ulcer on 3/9/2026, and the DON confirmed there was no documented treatment provided that day. A second component of the deficiency concerns the facility’s failure to follow updated wound provider orders for the resident’s bilateral heel unstageable pressure ulcers. On 3/4/2026, physician orders directed cleansing both heels with normal saline, patting dry, applying iodosorb, and covering with a dry dressing daily for 30 days. A subsequent wound assessment on 3/25/2026 indicated the wound provider ordered betadine and dry dressing daily to both heels, and physician orders dated the same day specified cleansing with normal saline, patting dry, applying betadine, and covering with a dry dressing daily for 30 days to each heel. The care plan was also updated on 3/25/2026 to reflect betadine treatment to the left heel. Despite the new 3/25/2026 orders, the March TAR showed that from 3/26/2026 through 3/31/2026, nurses administered both betadine and iodosorb daily to the resident’s heels. During interview and record review, the DON stated that treatment nurses should have called the wound provider to clarify which order to continue when the new betadine order was added, given the prior iodosorb order, and noted concern about a possible drug interaction and the combination being too strong for the resident’s skin. Treatment Nurse 1 confirmed that both betadine and iodosorb were applied to the bilateral heels during that period and stated that the wound care order should have been clarified when the wound provider was at the facility on 3/25/2026. Facility policies on pressure ulcer management and wound documentation required individualized care plans, appropriate wound solutions and dressings per provider guidelines, and documentation at each treatment that matches the TAR, which were not followed in these instances.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.